ACLX
Price
$62.02
Change
+$1.33 (+2.19%)
Updated
Apr 17 closing price
Capitalization
3.41B
20 days until earnings call
VCEL
Price
$41.23
Change
+$0.41 (+1.00%)
Updated
Apr 17 closing price
Capitalization
2.07B
19 days until earnings call
Ad is loading...

ACLX vs VCEL

Header iconACLX vs VCEL Comparison
Open Charts ACLX vs VCELBanner chart's image
Arcellx
Price$62.02
Change+$1.33 (+2.19%)
Volume$833.02K
Capitalization3.41B
Vericel
Price$41.23
Change+$0.41 (+1.00%)
Volume$343.27K
Capitalization2.07B
ACLX vs VCEL Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. VCEL commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and VCEL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (ACLX: $62.02 vs. VCEL: $41.23)
Brand notoriety: ACLX and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 119% vs. VCEL: 76%
Market capitalization -- ACLX: $3.41B vs. VCEL: $2.07B
ACLX [@Biotechnology] is valued at $3.41B. VCEL’s [@Biotechnology] market capitalization is $2.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACLX and VCEL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while VCEL’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 6 bearish.
  • VCEL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VCEL is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а +9.46% price change this week, while VCEL (@Biotechnology) price change was -1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

VCEL is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.41B) has a higher market cap than VCEL($2.07B). ACLX YTD gains are higher at: -19.129 vs. VCEL (-24.913). VCEL has higher annual earnings (EBITDA): 16.6M vs. ACLX (-99.06M). ACLX has more cash in the bank: 587M vs. VCEL (116M). ACLX has less debt than VCEL: ACLX (54.1M) vs VCEL (98.8M). VCEL has higher revenues than ACLX: VCEL (237M) vs ACLX (108M).
ACLXVCELACLX / VCEL
Capitalization3.41B2.07B165%
EBITDA-99.06M16.6M-597%
Gain YTD-19.129-24.91377%
P/E RatioN/A206.15-
Revenue108M237M46%
Total Cash587M116M506%
Total Debt54.1M98.8M55%
FUNDAMENTALS RATINGS
VCEL: Fundamental Ratings
VCEL
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
51
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXVCEL
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 25 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
Bearish Trend 5 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
70%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with RCKT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+2.19%
RCKT - ACLX
55%
Loosely correlated
+2.93%
ROIV - ACLX
54%
Loosely correlated
+1.30%
KRYS - ACLX
54%
Loosely correlated
+2.35%
DNLI - ACLX
54%
Loosely correlated
+1.51%
KYMR - ACLX
52%
Loosely correlated
+3.80%
More

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with KRYS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
+1.00%
KRYS - VCEL
39%
Loosely correlated
+2.35%
ACLX - VCEL
37%
Loosely correlated
+2.19%
BEAM - VCEL
36%
Loosely correlated
+2.29%
LENZ - VCEL
35%
Loosely correlated
+3.30%
RXRX - VCEL
34%
Loosely correlated
+3.38%
More